These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 37485878)

  • 21. Sitagliptin as add-on therapy in insulin deficiency: biomarkers of therapeutic efficacy respond differently in type 1 and type 2 diabetes.
    Giampietro O; Giampietro C; Bartola LD; Masoni MC; Matteucci E
    Drug Des Devel Ther; 2013; 7():99-104. PubMed ID: 23439744
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of low dose metformin in adolescents with type I diabetes mellitus: a randomized, double-blinded placebo-controlled study.
    Nadeau KJ; Chow K; Alam S; Lindquist K; Campbell S; McFann K; Klingensmith G; Walravens P
    Pediatr Diabetes; 2015 May; 16(3):196-203. PubMed ID: 24698216
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The addition of metformin in type 1 diabetes improves insulin sensitivity, diabetic control, body composition and patient well-being.
    Moon RJ; Bascombe LA; Holt RI
    Diabetes Obes Metab; 2007 Jan; 9(1):143-5. PubMed ID: 17199734
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Insulin resistance in type 1 diabetes managed with metformin (INTIMET): Study protocol of a double-blind placebo-controlled, randomised trial.
    Snaith JR; Samocha-Bonet D; Evans J; Liu Z; Kowalski G; Bruce C; Holmes-Walker DJ; Greenfield JR
    Diabet Med; 2021 Sep; 38(9):e14564. PubMed ID: 33774848
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The relationship between obesity, glycemia and leptin level of type 2 diabetes mellitus patients with metabolic syndrome.
    Marusyn OV
    Wiad Lek; 2018; 71(6):1165-1168. PubMed ID: 30267494
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Direct comparison among oral hypoglycemic agents and their association with insulin resistance evaluated by euglycemic hyperinsulinemic clamp: the 60's study.
    Derosa G; Maffioli P; Salvadeo SA; Ferrari I; Gravina A; Mereu R; Palumbo I; D'Angelo A; Cicero AF
    Metabolism; 2009 Aug; 58(8):1059-66. PubMed ID: 19394976
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Addressing insulin resistance in Type 1 diabetes.
    Pang TT; Narendran P
    Diabet Med; 2008 Sep; 25(9):1015-24. PubMed ID: 19183305
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effects of metformin and diet on plasma testosterone and leptin levels in obese men.
    Ozata M; Oktenli C; Bingol N; Ozdemir IC
    Obes Res; 2001 Nov; 9(11):662-7. PubMed ID: 11707532
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metformin in combination with structured lifestyle intervention improved body mass index in obese adolescents, but did not improve insulin resistance.
    Clarson CL; Mahmud FH; Baker JE; Clark HE; McKay WM; Schauteet VD; Hill DJ
    Endocrine; 2009 Aug; 36(1):141-6. PubMed ID: 19387874
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Leptin and body fat in type 2 diabetes and monodrug therapy.
    Sivitz WI; Wayson SM; Bayless ML; Larson LF; Sinkey C; Bar RS; Haynes WG
    J Clin Endocrinol Metab; 2003 Apr; 88(4):1543-53. PubMed ID: 12679437
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rosiglitazone therapy improves insulin resistance parameters in overweight and obese diabetic patients intolerant to metformin.
    Derosa G; Salvadeo SA; D'Angelo A; Fogari E; Ragonesi PD; Ciccarelli L; Piccinni MN; Ferrari I; Gravina A; Maffioli P; Cicero AF
    Arch Med Res; 2008 May; 39(4):412-9. PubMed ID: 18375253
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Current status of metformin in addition to insulin therapy in adult patients with type 1 diabetes mellitus: An analysis from the Guangdong Type 1 Diabetes Mellitus Translational Medicine Study.
    Qiu L; Ling P; Yang D; Luo S; Zheng X; Liang H; Yuan Y; Liang G; Xu W; Yao B; Yan J; Weng J
    J Diabetes; 2020 Oct; 12(10):754-760. PubMed ID: 32040241
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Extended release metformin for metabolic control assistance during prolonged clozapine administration: a 14 week, double-blind, parallel group, placebo-controlled study.
    Carrizo E; Fernández V; Connell L; Sandia I; Prieto D; Mogollón J; Valbuena D; Fernández I; de Baptista EA; Baptista T
    Schizophr Res; 2009 Aug; 113(1):19-26. PubMed ID: 19515536
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metformin and insulin in type 1 diabetes: the first step.
    Meyer L; Guerci B
    Diabetes Care; 2003 May; 26(5):1655-6. PubMed ID: 12716857
    [No Abstract]   [Full Text] [Related]  

  • 35. Metformin ameliorates treatment of obese type 2 diabetic patients with mental retardation; its effects on eating behavior and serum leptin levels.
    Komori T; Yoshida F; Nakamura J; Miyazaki S; Miura H; Iguchi A
    Exp Clin Endocrinol Diabetes; 2004 Sep; 112(8):422-8. PubMed ID: 15372361
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metformin reduces weight, centripetal obesity, insulin, leptin, and low-density lipoprotein cholesterol in nondiabetic, morbidly obese subjects with body mass index greater than 30.
    Glueck CJ; Fontaine RN; Wang P; Subbiah MT; Weber K; Illig E; Streicher P; Sieve-Smith L; Tracy TM; Lang JE; McCullough P
    Metabolism; 2001 Jul; 50(7):856-61. PubMed ID: 11436194
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metformin use as an adjunct to insulin treatment.
    Gunton JE; Twigg SM
    Med J Aust; 2003 Jun; 178(11):591-2. PubMed ID: 12765513
    [No Abstract]   [Full Text] [Related]  

  • 38. Long-term treatment with metformin in obese, insulin-resistant adolescents: results of a randomized double-blinded placebo-controlled trial.
    van der Aa MP; Elst MA; van de Garde EM; van Mil EG; Knibbe CA; van der Vorst MM
    Nutr Diabetes; 2016 Aug; 6(8):e228. PubMed ID: 27571249
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Association between levels of serum leptin and insulin resistance in patients with polycystic ovary syndrome].
    Cheng X; Guo J; Xie J
    Zhonghua Liu Xing Bing Xue Za Zhi; 2014 Dec; 35(12):1389-91. PubMed ID: 25623461
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metformin as additional therapy in adolescents with poorly controlled type 1 diabetes: randomised placebo-controlled trial with aspects on insulin sensitivity.
    Särnblad S; Kroon M; Aman J
    Eur J Endocrinol; 2003 Oct; 149(4):323-9. PubMed ID: 14514347
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.